METHOD OF DIAGNOSING NEPHROTIC SYNDROME

Details for Australian Patent Application No. 2002332832 (hide)

Owner CIPHERGEN BIOSYSTEMS, INC.

Inventors SHIWA, Mieko; SAITO, Kenji; TOMOSUGI, Naohisa

Pub. Number AU-A-2002332832

PCT Number PCT/US02/28152

PCT Pub. Number WO2003/019193

Priority 60/315,774 30.08.01 US

Filing date 29 August 2002

Wipo publication date 10 March 2003

International Classifications

G01N 033/53 Investigating or analysing materials by specific methods not covered by groups - Immunoassay

G01N 033/543 Investigating or analysing materials by specific methods not covered by groups - with an insoluble carrier for immobilising immunochemicals

G01N 033/566 Investigating or analysing materials by specific methods not covered by groups - using specific carrier or receptor proteins as ligand binding reagent

C12N 001/00 Micro-organisms, e.g. protozoa

H01J 049/00 Particle spectrometers or separator tubes

Event Publications

13 February 2003 Complete Application Filed

  Priority application(s): 60/315,774 30.08.01 US

5 June 2003 Application Open to Public Inspection

  Published as AU-A-2002332832

10 June 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002332833-ANTI-LIME SCALE CLEANING COMPOSITION

2002332831-AN SIL-6R/IL-6 FUSION PROTEIN COOPERATES SYNERGISTICALLY WITH HGF TO STIMULATE HEPATOCYTE PROLIFERATION IN VIVO